*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Sitagliptin Impurity 57 is a critical degradation product and process-related impurity of the antidiabetic agent Sitagliptin. Synthesized via specific <strong>peptide coupling</strong> side reactions, its molecular formula is <strong>C16H25N5O4S</strong> (CAS: 1082797-45-0). This compound serves as a reference standard for HPLC method validation.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical QC:</strong> Used in stability-indicating assays to quantify degradation products during shelf-life studies.</li>
<li><strong>R&D Validation:</strong> Employed to establish specificity limits in analytical methods for active pharmaceutical ingredients.</li>
<li><strong>Regulatory Compliance:</strong> Supports ICH Q3A/B guidelines for reporting unknown impurities in drug substance dossiers.</li>
</ul>
<h3>Precautions</h3>
<p>Storage requires sealed containers at <strong>-20°C</strong> under inert atmosphere to prevent hydrolysis. Handling mandates PPE including nitrile gloves and safety goggles due to potential sensitization risks. Strict adherence to GMP protocols is required for all laboratory usage.</p>